Ignite Creation Date:
2025-12-24 @ 7:47 PM
Ignite Modification Date:
2025-12-25 @ 5:24 PM
Study NCT ID:
NCT01353703
Status:
COMPLETED
Last Update Posted:
2020-01-02
First Post:
2011-05-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04-16
Start Date Type:
ACTUAL
Primary Completion Date:
2013-02-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-02-25
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-12
First Submit QC Date:
None
Study First Post Date:
2011-05-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-05-26
Results First Submit QC Date:
None
Results First Post Date:
2019-01-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-04-26
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2019-12-27
Last Update Post Date:
2020-01-02
Last Update Post Date Type:
ACTUAL